Background: Individuals with repaired tetralogy of Fallot develop pulmonary regurgitation that may cause symptoms (dyspnea, chest pain, palpitations, fatigue, presyncope, and syncope), impair functional capacity, and may affect health-related quality of life. Surgical pulmonary valve replacement is the gold standard of treatment although transcatheter pulmonary valve replacement is becoming more common. Patients want to know whether less invasive options are as good. Aims: This analysis aimed to examine the differences in surgical versus transcatheter pulmonary valve replacement effects in terms of physiological/biological variables, symptoms, functional status and health-related quality of life. Methods: This quasi-meta-analysis included 85 surgical and 47 transcatheter pulmonary valve replacement studies published between 1995-2016. Results: In terms of physiological/biological variables, both surgical and transcatheter pulmonary valve replacement improved pulmonary regurgitation and systolic and diastolic right ventricular volume indices but not heart function. In the left heart, only surgical pulmonary valve replacement improved heart function. Only transcatheter pulmonary valve replacement improved left ventricular end-diastolic indices and neither improved endsystolic indices. Only surgery has been demonstrated to decrease QRS duration but there is little evidence of arrhythmia reduction. Symptom change is poorly documented. Functional class improves but exercise capacity generally does not. Some aspects of health-related quality of life improve with surgery and in one small transcatheter pulmonary valve replacement study. Conclusion: Transcatheter and surgical pulmonary valve replacement compare favorably for heart remodeling. Exercise capacity does not change with either technique. Health-related quality of life improves after surgical pulmonary valve replacement. There are numerous gaps in documentation of changes in arrhythmias and symptoms.
Introduction
Congenital heart disease (CHD) is the most common birth defect in the USA affecting nearly 1% of births. 1 Tetralogy of Fallot (TOF) is the most common cyanotic CHD (5.4% of CHD) 2 and has four features: (a) a membranous ventricular septal defect; (b) an over-riding aorta; (c) right ventricular outflow tract obstruction; and (d) right ventricular hypertrophy. Successful surgical repair of TOF has been performed since 1955. 3 Thirty-year survival is currently 80-90%. [4] [5] [6] [7] Repair of TOF leaves pulmonary regurgitation (PR) that is well tolerated for years, but about 36-40% 8, 9 of adolescents and adults with repaired TOF will need a pulmonary valve replacement (PVR) within 30 years of their initial childhood surgery. PVR has become the most common cardiac operation performed in adults with CHD. 10 The problems that occur with PR in repaired TOF are well suited to the use of Wilson and Cleary's conceptual model of health-related quality of life (HRQOL) 11 (see Supplementary Material, Figure 1 ). In PR after TOF repair, the primary problems are the biological/physiological variables, with PR initiating many of the other sequelae (see Supplementary Material, Figure 2 ), leading to ventricular arrhythmias (14.6%), 12 sustained atrial tachyarrhythmias (20.1%), 12 right ventricular (RV) failure, 13 and ultimately left ventricular (LV) failure. 13 About 40% of individuals with repaired TOF will die of heart failure and about 10% will suffer sudden death, likely arrhythmic in origin. 14 The deleterious effects of PR and heart failure in repaired TOF have been identified as top priority research priorities in adult CHD. 15, 16 As a result of the biological/physiological variables, symptoms such as dyspnea on exertion, fatigue, palpitations, chest pain, presyncope, and syncope occur affecting about 45% of TOF patients. 4 Symptoms impair functional status 4 including exercise capacity and this can impair general health perceptions such as HRQOL. HRQOL has an impact on overall quality of life that is also influenced by nonmedical factors.
Currently, surgical PVR is considered the gold standard of treatment for PR but is very invasive requiring a sternotomy, the use of cardiopulmonary bypass, and weeks of recovery. The biologic valves used eventually deteriorate and require replacement. Although mechanical valve PVR can be used, concern about the effects in the low-pressure pulmonary circulation with the requirement for anticoagulation in active individuals has limited its use. Mechanical PVR will not be considered in this review. The reader is referred to a meta-analysis on this topic. 17 Transcatheter (TC) PVR approaches have been developed for TOF with a right ventricle to pulmonary artery conduit. 18, 19 More recently PVR approaches with native outflow tracts (without conduits) have been developed including hybrid (combination of TC and surgical techniques) to address the problem of outflow tracts that are larger than the available valves. These approaches vary in their invasiveness from a small 5-10 cm incision 20, 21 to full sternotomy [22] [23] [24] [25] and some approaches use cardiopulmonary bypass. 21 When the surgical or TC valve deteriorates, replacement via TC PVR techniques can be done (valvein-valve PVR). [26] [27] [28] [29] [30] Although most patients prefer less invasive approaches to PVR they have questions for healthcare professionals about how they compare with surgical PVR. There are no known comparisons of the TC, hybrid, and surgical PVR at this time making it difficult for providers to advise patients.
Therefore, this review sought to address whether there are differences between TC and hybrid PVR versus surgical PVR on biological variables (heart remodeling and function, arrhythmias), symptoms, functional status, and HRQOL in patients with PR after TOF repair. This review did not address the literature on valve longevity.
Methods
This review was undertaken using a quasi-meta-analysis technique (integrative review with meta-analysis of the quantitative variables). The Meta-Analyses of Observational Studies in Epidemiology 31 criteria were used in reporting the results. A medical librarian was consulted for search design (see Supplementary Material, Table 1 ). The inclusion and exclusion criteria are shown in Supplementary Material, Table 1 .
The search process is shown in Supplementary Material, Figure 3 . The Wilson and Cleary 11 framework guided variable extraction and reporting. All outcome measures were extracted into Excel spreadsheets for comparison. For multiple point outcomes in a study, the outcomes with the longest follow-up time were used provided the number of observations was not extremely small. Where studies reported subgroups of patients, only those with PR were used. Data from magnetic resonance imaging (MRI), EKG, and cardiopulmonary exercise tests were analyzed using Comprehensive Meta-Analysis Version 3 (Biostat, Englewood, New Jersey, USA) where possible to assess combined effect size from multiple measures. This analysis depended on pre-and post-PVR measures, and p values for each study. Studies found to have incorrect p values based on the means were excluded. Studies not using pre-and post-testing were excluded from the quantitative analysis but were included in the qualitative synthesis. The level of significance was set at p<0.05. A random effects model was used for testing due to study heterogeneity. 32 Although the first author performed the search and data extraction, all authors guided the analysis was to ensure robust conclusions.
Results
General characteristics of the studies are described first followed by patient outcomes organized according to the Wilson and Cleary model. 11 
Study characteristics
A total of 47 TC PVR manuscripts were reviewed (37 with primarily conduit implants and 10 with primarily native RV outflow tract implants with 3354 subjects). These were compared and contrasted with outcomes from the gold standard surgical PVR (85 manuscripts) with 6196 subjects (see Supplementary Material, Table 2 ). There were insufficient hybrid studies (four) and therefore an analysis of hybrid PVR was not undertaken. Studies involving exclusively valve-in-valve implants were excluded. Many of the studies were conducted with heterogeneous samples (patients with different diagnoses and past surgeries; few studies were conducted solely with patients with repaired TOF with primary PR) but only those reporting TOF patients as the largest subgroup were included. Study participants ranged in age from older children to middle-aged adults.
The sample sites were, in descending order, the USA, the Netherlands, Canada, Belgium, the UK, France, Korea, Germany, France, and single studies from other European and Asian countries. Sites were large pediatric and/or adult academic teaching hospitals. Sample sizes varied from 5-404 subjects. There were 16 single-center and 31 multisite TC PVR studies whereas most of the surgical studies were single-center studies. There may be some subject overlap between studies, particularly in ongoing trials but this was difficult to ascertain.
The TC study designs were a mix of retrospective and prospective cohort designs (sometimes difficult to determine) versus predominantly retrospective cohorts in surgical PVR. There were a few matched cohort studies, all but one in the surgical group. There was one randomized study comparing surgical PVR with and without RV remodeling procedures. 33 In contrast to the surgical PVR literature dating back several decades, the first TC study cited was in 2006.
Patient outcomes
Biological and physiologic variables. Assessment of right and left heart volumes, regurgitant fraction (RF) of the pulmonary valve, and heart function (ejection fraction) with cardiac MRI/magnetic resonance angiography (MRA) was performed to determine if the heart remodels and ventricular function normalizes after PVR. Some studies used paired results and others did not therefore only studies with paired results were used in the meta-analyses. Cardiac MRI/MRA was performed in 31 surgical studies and 15 TC studies from a median of six months to 3.5 years and 1-2 days to 16 months post-operatively (most at six months) respectively.
Heart volume indices. RV end-diastolic index (RVEDVI) significantly decreased from a pooled pre-PVR value of 129.77 to 106.07 ml/m 2 after TC PVR (p<0.001) and from a pooled pre-PVR value of 173.96 to 112.26 ml/m 2 after surgical PVR (p<0.001). RV end-systolic volume index (RVESVI) was significantly reduced from a pooled value of 68.00 to 56.71 ml/m 2 after TC PVR (p<0.001) and from 100.13 to 60.84 ml/m 2 (p<0.001) after surgical PVR. Pulmonary valve RF decreased significantly from a pooled value of 32.56% to 3.55% after TC PVR (p<0. 001) and from 45.77% to 6.37% (p<0.001) after surgical PVR (see Arrhythmias. QRS duration on the 12-lead EKG (electrocardiogram) was significantly reduced after surgical PVR (pre-PVR pooled value of 156 ms to 150 ms, p<0.001) but not after TC PVR (pre-PVR pooled value of 142 ms both before and after PVR, p=0.729). There were only two studies (both at six months post-procedure) in the TC group (one study without enough information for metaanalysis not included). Surgical QRS duration was measured in 28 studies (19 with analyzable data) from less than one month to nine years post-operatively. See Figure 5 for QRS duration forest plots. Some studies reported a reduction in arrhythmias with PVR 34 but the results were inconsistent. [35] [36] [37] With the variety of concomitant procedures for arrhythmias undertaken with surgical PVR (cryoablation, right atrial and bi-atrial MAZE procedures, ablation of ventricular tachycardia) it was difficult to ascertain what effect PVR has on arrhythmia status.
Procedural morbidity and mortality. The surgical PVR studies reported a 30-day mortality of 1% (range 0-10% in 41 studies). In contrast, although there is 0.3% mortality (range 0-1.6% in 18 studies) after TC PVR there can be procedural failure as it is impossible to accurately assess for aortic (incidence 9.2%) and coronary artery compression (incidence 4%) without balloon testing at implantation. 38 This does not occur with surgical PVR. In addition, stent or valve embolization is possible (incidence of 0.5-4.2% in studies reporting this complication) 30, 39-44 but many studies had none. Unlike surgical valves, the Melody TC valve has problems with stent fracture (34 studies with an incidence of 0-33.3% in this review). As fractures can impair valve function, prestenting has now become common (the stented valve is delivered into at least one stent placed in the right ventricle outflow tract) with a reduction in stent fracture. The Sapien TC valve has few reports of stent fracture due to the stronger stent metal. The surgical literature reports 5-and 10-year survival of 92% 45 to 98% 46 and 76.4% 47 to 100% 48 after PVR respectively. There is insufficient long-term follow-up to provide this data for TC PVR. Hospital stay was a median of 6.5 days and two days respectively for the surgical and TC studies.
Symptoms. One would expect symptoms to improve if the heart remodels after PVR. None of the TC studies evaluated the percentage of patients with specific symptoms such as dyspnea on exertion, fatigue, palpitations, chest pain, presyncope, and syncope before and after PVR. Two studies 48, 49 evaluated symptoms in surgical PVR patients but no statistical significance testing was used. It was often unclear at what time point the symptoms were re-evaluated post-PVR. Some studies used the New York Heart Association (NYHA) functional class as a surrogate for symptoms.
Functional status. The most common indicator of functional status examined was the NYHA functional class. After TC and surgical PVR, NYHA functional class decreased significantly in all studies, but the multiple reporting methods made statistical comparison difficult. Many studies presented illustrations of NYHA functional class decrease but absolute numbers or percentages were lacking. Cardiopulmonary exercise testing was used in a smaller number of studies (12 TC, nine surgical) to examine exercise capacity at less than one month to 3.4 years post-PVR (most TC studies were at one year or less). Not all studies were maximal (interpretable). Peak oxygen consumption (VO 2 max) did not significantly increase after surgical PVR (pre-PVR pooled value of 26.75 ml/kg/min, post-PVR 27.15 ml/ kg/min, p=0.885) but it did improve after TC PVR (pre-PVR pooled value of 31.69 ml/kg/min to 34.76 ml/kg/ min, p=0.005). See Figure 6 for forest plots of VO 2 max. Very few studies reported other cardiopulmonary exercise variables.
General health perceptions (HRQOL). Five surgical studies 25, 33, [50] [51] [52] examined HRQOL using the 36-item short form survey (SF-36) 53 tool six months to four years post-operatively. One pediatric surgical study 33 used the Child Health Questionnaire 54 -Parent Form and another used a 10-item short form for children. 25 Significant improvement occurred in many of the SF-36 measures after surgical PVR indicating improved HRQOL. There was only one study with 13 subjects examining HRQOL measured with the SF-36 instrument six months after TC PVR. 55 Only physical health scores and health transition scores significantly increased. Four of the subscales had perfect scores before PVR therefore making it impossible to assess any improvement. 55 No disease-specific HRQOL instruments were used. The studies lacked definitions for HRQOL and failed to distinguish this concept from overall quality of life.
Infective endocarditis
Although this study did not specifically examine infective endocarditis (IE) due to the problems of multiple definitions in the literature and the lack of follow-up for IE in many of the surgical studies, a few important points should be made. A higher incidence of IE has been noted with the Melody bovine jugular valve with reports of 0.1-14.3% 44,56-67 and a 2.4% annulated rate of IE. 68 Higher rates of IE have been reported in surgical bovine jugular vein conduits versus homografts. 69 The reason for the high incidence of IE in bovine jugular conduits and valves is not clear at this time.
Discussion

Biological and physiologic variables
If one expects improvement of physiologic variables after PVR, assessment of the variables needs to be performed after adequate time for cardiac remodeling to occur. There was no consistent time frame for conducting MRIs after PVR. One of the studies reported MRI results performed only 1-2 days after PVR 70 and several other studies performed post-PVR MRIs within the first month, 44,71 a time frame likely providing insufficient time for ventricular remodeling. Most studies reported only single post-PVR MRI measures. Of the surgical PVR studies, there are three that report serial MRI data. [72] [73] [74] The RVEDVI, RVESVI, and RVEF showed a small improvement from 7-8 months post-PVR to 19-22 months post-PVR although the changes from eight months to 22 months were not statistically significant. 73, 74 A third study 72 showed a small reduction in RVESVI, no change in RVEDVI, and a slight increase in RVEF (all non-significant from changes up to one year post-PVR) at 1-2 years. This was then followed by a slow increase in RVEDVI and RVESVI over the following years up to 10 years with a progressive increase in RF over time as well. LVEF and RVEF remained stable until after seven years when they started to decline. 72 A recent study 62 of unpaired volume indices for a mean of 4.5 years after TC PVR showed that there was no further remodeling of heart volume or function after one year. This should be confirmed by future studies that have paired MRI/MRA measures. Further studies with serial MRI assessments would be useful to confirm when remodeling is complete and if the right ventricle starts to dilate again. Serial MRI studies are also needed to understand how the heart responds to a second or third PVR, as this is what many repaired TOF patients will face over their lifetime. Heart volume indices. This study found that implanting a valve, either surgical or TC, improves PR immediately followed by significant reduction in size of the right ventricle in diastole due to the resolution of PR. In TC PVR, the LVEDVI increased significantly but in surgical PVR there was no change. It is unclear if the surgical LVEDVI will not change or lags behind RV recovery as the effects on the left ventricle are indirect and also subject to surgical insults such as cardiopulmonary bypass. The fact that TC PVR was performed at smaller right ventricular volumes may also cause some of the differences.
Systolic function. Left heart systolic function significantly improved after surgical PVR, likely due to decompression of the dilated right ventricle and a shift of the interventricular septum back to a normal position. This results in improved filling of the left ventricle. 75 LVEF did not improve after TC PVR but this may be due to a higher LVEF before the PVR. Right ventricular systolic function did not change after surgical and TC PVR. It may be that further time is required for recovery of RV function. Some studies have found that recovery occurs in individuals with less dilated right ventricles but these results have been inconsistent. 33, [76] [77] [78] [79] [80] [81] Larger trials with serial followup are needed to determine if there is a threshold above which recovery will not occur. Some of the issues related to RV contractility may be measurement-related. Ferraz Cavalcanti and co-authors 82 found that surgical PVR studies using corrected measures of RVEF versus non-corrected measures demonstrated a significant increase in RVEF. However, measurement methods are not specified in some studies.
There may be other biologic factors that determine ventricular remodeling such as the duration of cyanosis before primary TOF repair. Genetic factors may impact outcomes of PVR given the high prevalence of genetic syndromes with TOF. 83, 84 Age may play a role in ventricular remodeling as Borik and colleagues 62 showed that TC PVR at less than 16 years of age was associated with better ventricular remodeling.
Two studies reported MRI/MRA parameters after hybrid PVR but owing to incomplete data they could not be meta-analyzed and therefore comparisons were limited to TC PVR versus surgical PVR. In addition, there is considerable variability in the hybrid procedures that make comparisons difficult. Many of the hybrid PVR approaches are supported by little more than feasibility data with short follow-up at this time.
Arrhythmias
This study found that surgical PVR significantly decreases QRS duration. Only two studies, 57,85 document QRS duration reduction in TC PVR (only one with sufficient data to be included in the meta-analysis). The differences may be due to the fact that the RV sizes were substantially larger in the surgical group versus the TC group. Smaller RV size promotes more rapid interventricular conduction. Arrhythmia reduction has not been well documented despite decreases in the QRS duration for surgical PVR. Few studies report anything other than qualitative summaries of arrhythmias. Many arrhythmias may be subclinical and only found on longer-term surveillance such as Zio patch (iRhythm Technologies, San Francisco, California, USA). Regular, longer-term arrhythmia surveillance would improve information on prevalence of arrhythmias. Definitions of arrhythmias would also be helpful as these were often lacking.
Symptoms
Patients often make decisions to undergo PVR due to symptoms. Although many TC patients anecdotally report subjective symptom relief, this has yet to be clearly documented for each symptom such as dyspnea on exertion, chest pain, palpitations, fatigue, presyncope, and syncope. Only two surgical PVR studies 48, 49 described specific symptoms. Some studies used NYHA functional class as a surrogate for symptomatology but percentage of symptom change with PVR would help patients make decisions about whether or not to proceed with PVR.
Functional status
NYHA functional class was decreased after PVR suggestive of improvements in exercise capacity, but the measures varied widely (often pictorially without numbers) so a quantitative comparison was not performed. Some studies reported outcomes for all four functional classes; others grouped some categories together. Future studies should report absolute numbers and percentages of subjects in each NYHA class before and after PVR. It was unclear in many studies when the NYHA functional classification was performed after PVR.
NYHA is a subjective evaluation of functional status. In CHD functional decline often occurs slowly and patients underestimate their exercise capacity. 86 Therefore the American adult CHD guidelines recommend objective cardiopulmonary exercise testing. 87 VO 2 max, a measure of aerobic capacity, did not significantly change with surgical PVR but it did with TC PVR. However, there were a limited number of studies in both groups that could be included in the analysis so these results are preliminary. Also, VO 2 max was lower in the surgical PVR group pre-PVR and this may influence the results. Most of the cardiopulmonary exercise studies were performed about six months after PVR and further improvement may occur later in the course of recovery, especially if heart remodeling takes time. One study with unpaired exercise tests performed at a median of 0.53 and 3.4 years after TC PVR showed that although there were no significant changes in VO 2 max or work performed at the earlier measurement, both changed significantly at the later test. 62 Therefore serial post-PVR measures or measures at one year or beyond are recommended in future studies.
General health perceptions
Five studies examined HRQOL in surgical PVR and one study in TC PVR and all found some improvements as measured by a generic HRQOL instrument. Some pre-PVR ceiling effects were observed in subscale measures making it impossible to assess any improvement post-PVR. Several studies 88, 89 have shown that the SF-36 may not have sufficient sensitivity in valve patients, particularly those who are young with few comorbidities. Diseasespecific HRQOL measures alone or in combination with generic HRQOL measures may yield more information than generic tools alone. Instruments accommodating both pediatric and older age groups may be needed.
The strength of the association between symptomatology, functional status, and HRQOL before and various types of PVR should be investigated to understand which factors affect HRQOL the most and what treatment targets may benefit patients most. As well, other moderators of HRQOL such as the personal and environmental factors in the Wilson and Cleary model 11 need further study.
Gaps in the literature and implications for research
The lack of variable definitions created important heterogeneity in the reporting of outcomes amongst the studies. More precise definitions, or standardized definitions would facilitate cross-study comparison, pooling of results in meta-analyses, or in multi-site studies. Longer-term follow-up of TC PVR and hybrid PVR is needed to compare with the long-term surgical PVR outcomes. Outcome measures at least one year post-PVR and serial measures are needed to understand how the heart remodels and whether arrhythmias change over time after cardiac remodeling. As more experience is reported with TC valves, durability versus surgical valves will require further study.
Precision indicators and effect sizes should be reported in future studies to facilitate meta-analyses and estimate power for future studies. When sample sizes are small pre-and post PVR paired measures would be useful, as significant differences can exist amongst subjects in small cohorts.
Only three TC studies were comprised solely of patients with TOF and none of the data were included in the metaanalyses. Of the surgical PVR studies, 53 included only patients with TOF and 31 contributed data to the metaanalyses. When the studies that were not completely patients with TOF were removed from the analyses, none of the meta-analyses outcomes changed. Future studies of TC PVR should address the TOF group separately.
Implications for practice
TC and surgical PVR compare favorably for short-term outcomes at this time. TCPVR had more increase in LVEDVI and exercise capacity (VO 2 max). Surgical PVR was superior for increase in LVEF. Surgical PVR had more decrease in QRS duration but there is no known difference in arrhythmias between the two techniques. No statement of comparability can be made for hybrid and valve-invalve versus surgical PVR at this time due to the limited literature. The information gained from this review can be used to inform health care professionals about the outcomes of TC PVR versus surgical PVR. They may use this information to educate patients about the expected risks, benefits, and outcomes of these procedures so that they can make an informed decision about which type of PVR they prefer. The information in this review provides initial benchmarking data to use in TC PVR programs for quality improvement initiatives. The Wilson and Cleary framework 11 was useful in organizing a large number of variables examined in the studies. Support for many of the relationships depicted in the concept map of TOF (Supplementary Material, Figure 2) were demonstrated in the studies although further study is needed to specify causal relationships.
Limitations
Although this review has examined PVR outcomes from a large number of studies, it is influenced by the factors identified above and the fact that almost all studies were observational cohorts, many of them retrospective. There was only one randomized controlled trial, which limits causal generalization. The heterogeneity of TC PVR studies and the small numbers of studies of valve-in-valve PVR and hybrid PVR prevent separate analyses at this time. Some studies include small numbers of patients with pulmonary regurgitation after treatment for pulmonic stenosis patients or mixed pulmonary regurgitation and stenosis that were not analyzed separately from the pulmonary regurgitation patients. As well as this, not all studies were comprised totally of TOF patients (particularly in the TC PVR group). However, the results of the meta-analyses are not changed when studies with other CHD diagnoses are included. The influence of genetic factors on outcomes was not explored nor was valve durability, or stent fracture.
There are several methodological limitations of this review. A single author conducted the review which may have introduced bias reducing the validity or generalizability of the results. Important studies may have been excluded in the search. There were five abstracts in languages other than English and four conference abstracts that were irretrievable. These omissions may have influenced the results. There was publication bias evident from the funnel plots (not shown). As a result, negative or small studies may have underreported, introducing bias. A review of this size also limits reporting in detail on any of the variables examined.
Few studies 40, 90 currently address indices of diastolic function despite the increasing recognition of the prevalence of both LV and RV diastolic dysfunction in repaired TOF (13.8% and 52.4% respectively in a multicenter cohort). 91 Diastolic dysfunction is a major determinant of exercise capacity 92 and an independent predictor of ventricular tachyarrhythmias 12 so further understanding of the diastolic dysfunction will be important.
Conclusions
TC PVR compares favorably with surgical PVR in terms of ventricular remodeling at this time but there is no improvement in arrhythmias with either PVR technique. Functional status may improve more with TC PVR but there are only a small number of studies to support this finding at present. Symptom improvement occurs but is poorly documented. Surgical PVR increases HRQOL but only one small study has investigated HRQOL in TC PVR. Longer follow-up of TC and hybrid PVR outcomes are needed. 
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